Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Ewing's sarcoma and related subtypes of primitive neuroectodermal tumours share a recurrent and specific t(11;22) (q24;q12) chromosome translocation, the breakpoints of which have recently been cloned. Phylogenetically conserved restriction fragments in the vicinity of EWSR1 and EWSR2, the genomic regions where the breakpoints of chromosome 22 and chromosome 11 are, respectively, have allowed identification of transcribed sequences from these regions and has indicated that a hybrid transcript might be generated by the translocation. Here we use these fragments to screen human complementary DNA libraries to show that the translocation alters the open reading frame of an expressed gene on chromosome 22 gene by substituting a sequence encoding a putative RNA-binding domain for that of the DNA-binding domain of the human homologue of murine Fli-1.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ewing’s sarcoma, a common pediatric cancer, is invariably associated with ETS gene translocations (182) that result in a fusion oncogene consisting of the 5′ end of EWS and the 3′ end of FLI1, or less frequently ERG, ETV1, ETV4, or FEV (Figure 1a) (183, 184).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [183]
Citations
Cites
Kozak, M. (1986) · Cell · doi:10.1016/0092-8674(86)90762-2 · Cited by 4,741
Transcriptional Regulation in Mammalian Cells by Sequence-Specific DNA Binding Proteins
Mitchell, P. J., & Tjian, R. (1989) · Science · doi:10.1126/science.2667136 · Cited by 3,114
RNA recognition: towards identifying determinants of specificity
Kenan, D. J., Query, C. C., & Keene, J. D. (1991) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(91)90088-d · Cited by 730
RNA-binding proteins as developmental regulators.
Bandziulis, R. J., Swanson, M. S., & Dreyfuss, G. (1989) · Genes & Development · doi:10.1101/gad.3.4.431 · Cited by 644
Turc-Carel, C., Aurias, A., Mugneret, F., Lizard, S., Sidaner, I., Volk, C., Thiery, J. P., Olschwang, S., Philip, I., Berger, M. P., et al. (1988) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(88)90285-3 · Cited by 466
Self-citationBen-David, Y., Giddens, E. B., Letwin, K., & Bernstein, A. (1991) · Genes & Development · doi:10.1101/gad.5.6.908 · Cited by 403
Chromosome Translocation in Peripheral Neuroepithelioma
Whang-Peng, J., Triche, T. J., Knutsen, T., Miser, J., Douglass, E. C., & Israel, M. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408303110907 · Cited by 399
Chromosomal Translocations in Ewing's Sarcoma
(1983) · New England Journal of Medicine · doi:10.1056/nejm198308253090817 · Cited by 330
Corden, J. L. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90236-5 · Cited by 327
Turc-Carel, C., Philip, I., Berger, M.-P., Philip, T., & Lenoir, G. M. (1984) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(84)90002-5 · Cited by 291
Research works printed but not linked: 8
- Aurias, A., Rimbaut, C., Buffe, C., Dubousset, J. & Mazabraud, A. N. Engl. J. Med. 309, 496–497 (1983).
- Turc-Carel, C., Philip, I., Berge, R. M. P., Philip, T. & Lenoir, G. M. N. Engl. J. Med. 309, 497–498 (1983).
- De Chadarevian, J. P., Vekemans, M. & Seemayer, T. A. N. Engl. J. Med. 311, 1702–1703 (1984).
- Cavazzana, A. O. et al. Adv. Neuroblastoma Res. 2, 463–473 (1988).
- Zucman, J. et al. Genes Chrom. Cancer (in the press).
- Douglass, E. C., Valentine, M., Green, A. A., Hayes, F. A. & Thompson, E. I. J. natn. Cancer Inst. 77, 1211–1213 (1986).
- Watson, D. K., Ascione, R. & Papas, T. S. Crit. Rev. Oncogenesis 1, 409–436 (1990).
- Rouleau, G. A. et al. Am. J. hum. Genet. 46, 323–328 (1990).
Cited by
Items 101–200 of 1,002
Oncoprotein TLS Interacts with Serine-Arginine Proteins Involved in RNA Splicing
Yang, L., Embree, L. J., Tsai, S., & Hickstein, D. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.27761 · Cited by 224
Jaboin, J. J., Wild, J., Hamidi, H., Khanna, C., Kim, C. J., Robey, R. W., Bates, S. E., & Thiele, C. J. (2002) · PubMed · Cited by 247
NR0B1 Is Required for the Oncogenic Phenotype Mediated by EWS/FLI in Ewing's Sarcoma
Kinsey, M., Smith, R., & Lessnick, S. L. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0090 · Cited by 214
Molecular Assays for Chromosomal Translocations in the Diagnosis of Pediatric Soft Tissue Sarcomas
Barr, F. G. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520310051029 · Cited by 225
Guillon, N., Tirode, F., Boeva, V., Zynovyev, A., Barillot, E., & Delattre, O. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004932 · Cited by 218
“In most cases, translocations occur between chromosomes 11 and 22, leading to the formation of the aberrant EWS-FLI1 chimeric transcription factor [3].”
BackgroundSelf-citationThe tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma
Parker, B. C., Annala, M. J., Cogdell, D. E., Granberg, K. J., Sun, Y., Ji, P., Li, X., Gumin, J., Zheng, H., Hu, L., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67144 · Cited by 215
“Since their original identification in blood cancers (1), fusion genes have been identified in many solid tumors, such as Ewing sarcoma (2), synovial sarcoma (3), prostate cancer (4, 5), lung cancer (6, 7), breast cancer (8), and ovarian cancer (9).”
BackgroundOettgen, P., Alani, R. M., Barcinski, M. A., Brown, L., Akbarali, Y., Boltax, J., Kunsch, C., Munger, K., & Libermann, T. A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.8.4419 · Cited by 215
“The involvement of ets factors in human carcinogenesis has recently been highlighted by the discovery of several distinct chromosomal translocations involving specific members of the ets family in different cancer types (10, 19, 20, 27, 57, 85).”
BackgroundHematopoietic lineage- and stage-restricted expression of the ETS oncogene family member PU.1
Hromas, R., Orazi, A., Neiman, R., Maki, R., Van Beveran, C., Moore, J., & Klemsz, M. (1993) · Blood · doi:10.1182/blood.v82.10.2998.2998 · Cited by 216
Sreekantaiah, C., Ladanyi, M., Rodríguez, E., & Chaganti, R. S. K. (1994) · PubMed · Cited by 215
Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors
Sandberg, A. A., & Bridge, J. A. (2003) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(03)00002-5 · Cited by 214
“EWS, which is rearranged in Ewing sarcoma (ES) encodes a putative RNA-binding protein containing a central RNA-binding RNP-1 motif [237].”
BackgroundSchleiermacher, G., Peter, M., Oberlin, O., Philip, T., Rubie, H., Mechinaud, F., Sommelet-Olive, D., Landman-Parker, J., Bours, D., Michon, J., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.006 · Cited by 210
Self-citationDobson, C. L. (1999) · The EMBO Journal · doi:10.1093/emboj/18.13.3564 · Cited by 207
“We have studied the role of the Mll–AF9 gene fusion made in mouse embryonic stem cells by an homologous recombination knockin.”
BackgroundJousset, C., Carron, C., Boureux, A., Quang, C. T., Oury, C., Dusanter‐Fourt, I., Charon, M., Levin, J., Bernard, O., & Ghysdael, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.1.69 · Cited by 207
“…oligomerization domain as a 65 amino acid region and related tumors of childhood as the result of specificwhich is conserved in a subset of the ETS proteins chromosomal translocations (Delattre et al., 1992; Zucmanincluding ETS-1, ETS-2, FLI-1, ERG-2 and GABPα in et al., 1993; Jeon et al., 1995).”
BackgroundGrohar, P. J., Woldemichael, G. M., Griffin, L. B., Mendoza, A., Chen, Q.-R., Yeung, C., Currier, D. G., Davis, S., Khanna, C., Khan, J., et al. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr156 · Cited by 202
TLS, EWS and TAF15: a model for transcriptional integration of gene expression
Law, W. J. (2006) · Briefings in Functional Genomics and Proteomics · doi:10.1093/bfgp/ell015 · Cited by 200
“respectively [5].”
Recent advances in the molecular pathogenesis of Ewing's sarcoma
Toomey, E. C., Schiffman, J. D., & Lessnick, S. L. (2010) · Oncogene · doi:10.1038/onc.2010.205 · Cited by 191
“In the context of this fusion, a strong transcriptional activation domain is contributed by EWS and an ETS-type DNA-binding domain is contributed by FLI (Delattre et al., 1992; May et al., 1993a, b; Lessnick et al., 1995).”
BackgroundMolecular Pathogenesis of Ewing Sarcoma: New Therapeutic and Transcriptional Targets
Lessnick, S. L., & Ladanyi, M. (2012) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130237 · Cited by 190
Le Deley, M.-C., Delattre, O., Schaefer, K.-L., Burchill, S. A., Koehler, G., Hogendoorn, P. C. W., Lion, T., Poremba, C., Marandet, J., Ballet, S., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.3585 · Cited by 199
Self-citationChimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite
Grünewald, T. G. P., Bernard, V., Gilardi-Hebenstreit, P., Raynal, V., Surdez, D., Aynaud, M.-M., Mirabeau, O., Cidre-Aranaz, F., Tirode, F., Zaidi, S., et al. (2015) · Nature Genetics · doi:10.1038/ng.3363 · Cited by 186
Self-citationMolecular Diagnosis of Clear Cell Sarcoma
Antonescu, C. R., Tschernyavsky, S. J., Woodruff, J. M., Jungbluth, A. A., Brennan, M. F., & Ladanyi, M. (2002) · The Journal of Molecular Diagnostics · doi:10.1016/s1525-1578(10)60679-4 · Cited by 198
Hung, Y. P., Fletcher, C. D. M., & Hornick, J. L. (2016) · Modern Pathology · doi:10.1038/modpathol.2016.31 · Cited by 196
A Molecular Function Map of Ewing's Sarcoma
Kauer, M., Ban, J., Kofler, R., Walker, B., Davis, S., Meltzer, P., & Kovar, H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005415 · Cited by 191
“a chromosomal translocation that results in the formation of a gene fusion between the EWSR1 locus and an ETS transcription factor gene, which in 85% of the cases is FLI1 [2].”
BackgroundSelf-citationEwing Sarcoma Family of Tumors
Khoury, J. D. (2005) · Advances in Anatomic Pathology · doi:10.1097/01.pap.0000175114.55541.52 · Cited by 195
“The most frequent of these translocations is t(11;22)(q24;q12), which is detected in 90– 95% of cases.(25,26) This leads to in-frame fusion of EWS at From the Department of Pathology, St.”
BackgroundRetroviral insertional mutagenesis as a strategy to identify cancer genes
Jonkers, J., & Berns, A. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(95)00020-g · Cited by 194
Gene regulation by Ets proteins
Janknecht, R. (1993) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(93)90014-4 · Cited by 192
Identification of an RNA Binding Specificity for the Potential Splicing Factor TLS
Lerga, A., Hallier, M., Delva, L., Orvain, C., Gallais, I., Marie, J., & Moreau-Gachelin, F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008304200 · Cited by 189
A novel zinc finger gene is fused to EWS in small round cell tumor
Mastrangelo, T., Modena, P., Tornielli, S., Bullrich, F., Testi, M. A., Mezzelani, A., Radice, P., Azzarelli, A., Pilotti, S., Croce, C. M., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203762 · Cited by 192
“We tested the tumor DNA for the presence of EWS gene alterations by Southern blot analyses using as probe a partial EWS cDNA clone (Delattre et al., 1992).”
MethodHu-Lieskovan, S., Zhang, J., Wu, L., Shimada, H., Schofield, D. E., & Triche, T. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2857 · Cited by 186
“These translocations fuse a heretofore unknown gene, termed EWS , on chromosome 22, with a member of the ETS family of developmentally regulated genes, most commonly FLI1 on chromosome 11 (2).”
BackgroundParham, D. M., Roloson, G. J., Feely, M., Green, D. M., Bridge, J. A., & Beckwith, J. B. (2001) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200102000-00001 · Cited by 193
Oberg, J. A., Glade Bender, J. L., Sulis, M. L., Pendrick, D., Sireci, A. N., Hsiao, S. J., Turk, A. T., Dela Cruz, F. S., Hibshoosh, H., Remotti, H., et al. (2016) · Genome Medicine · doi:10.1186/s13073-016-0389-6 · Cited by 188
“For example, results categorized as Targetable/ Diagnostic (n = 6) are as follows: BCR-ABL1; IDH1; PIK3CA; EML4-NTRK3; [STAT5B, KRAS, JAK1/ STAT5B, i7q]; and [TMEM106B-BRAF/ gain chr 7, LOH 9p], with non-bracketed results representing a single finding fitting two categories and results within brackets representing tho…”
BackgroundInfluentialMolecular mechanisms of inactivation of TGF-β receptors during carcinogenesis
Kim, S.-J., Im, Y.-H., Markowitz, S. D., & Bang, Y.-J. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(99)00039-8 · Cited by 188
Round cell sarcomas beyond Ewing: emerging entities
Antonescu, C. (2014) · Histopathology · doi:10.1111/his.12281 · Cited by 188
“ES/PNET is characterized by translocations that fuse EWSR1, located at chromosome 22q12, and a gene of the ETS family of transcription factors.(5) In 90–95% of cases there is a recurrent t(11;22)(q24; q12), resulting in a EWSR1–FLI1 gene fusion, which contains the N-terminal portion of EWSR1 and the C-terminal portion…”
BackgroundDrugs for ‘protein clouds’: targeting intrinsically disordered transcription factors
Dunker, A. K., & Uversky, V. N. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.09.005 · Cited by 174
Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma
Postel-Vinay, S., Véron, A. S., Tirode, F., Pierron, G., Reynaud, S., Kovar, H., Oberlin, O., Lapouble, E., Ballet, S., Lucchesi, C., et al. (2012) · Nature Genetics · doi:10.1038/ng.1085 · Cited by 176
“Ewing sarcoma is an aggressive bone tumor in children that is characterized by a specific translocation that fuses EWSR1 (22q12) to FLI1 (11q24) in approximately 85% of cases, or, in the majority of remaining cases, to a member of the ETS transcription factor family other than FLI1”
BackgroundSelf-citationTargeting the DNA Repair Pathway in Ewing Sarcoma
Stewart, E., Goshorn, R., Bradley, C., Griffiths, L. M., Benavente, C., Twarog, N. R., Miller, G. M., Caufield, W., Freeman, B. B., Bahrami, A., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.09.028 · Cited by 180
“Most EWS tumors have a translocation involving the EWS gene on chromosome 22 and the FLI gene on chromosome 11 (Delattre et al., 1992).”
BackgroundEWS-FLI1 and EWS-ERG Gene Fusions Are Associated With Similar Clinical Phenotypes in Ewing's Sarcoma
Ginsberg, J. P., de Alava, E., Ladanyi, M., Wexler, L. H., Kovar, H., Paulussen, M., Zoubek, A., Dockhorn-Dworniczak, B., Juergens, H., Wunder, J. S., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.6.1809 · Cited by 178
Self-citationThe Ewing Sarcoma Protein Regulates DNA Damage-Induced Alternative Splicing
Paronetto, M. P., Miñana, B., & Valcárcel, J. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.05.035 · Cited by 176
“The molecular pathogenesis of the fusion proteins has been ascribed to the generation of strong transcriptional activators harboring a potent activation domain contributed by EWS and retaining the DNA binding domain and specificity of the ETS gene (Delattre et al., 1992).”
BackgroundRocchi, A., Manara, M. C., Sciandra, M., Zambelli, D., Nardi, F., Nicoletti, G., Garofalo, C., Meschini, S., Astolfi, A., Colombo, M. P., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci36667 · Cited by 175
“EWS is characterized by the presence of recurrent chromosomal translocations that fuse the EWSR1 gene (encoding the EWS protein) on chromosome 22 with various ETS genes (12).”
BackgroundThe EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour
Lee, S. B., Kolquist, K. A., Nichols, K., Englert, C., Maheswaran, S., Ladanyi, M., Gerald, W. L., & Haber, D. A. (1997) · Nature Genetics · doi:10.1038/ng1197-309 · Cited by 180
Dauphinot, L., De Oliveira, C., Melot, T., Sevenet, N., Thomas, V., Weissman, B. E., & Delattre, O. (2001) · Oncogene · doi:10.1038/sj.onc.1204437 · Cited by 172
“The most frequent fusion gene links EWS and FLI-1 sequences and encodes a chimeric EWS-FLI-1 protein which includes the N-terminal transactivation domain of EWS and the C-terminal DNA binding domain of FLI-1 (Delattre et al., 1992).”
BackgroundSelf-citationMechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma
Sankar, S., Bell, R., Stephens, B., Zhuo, R., Sharma, S., Bearss, D. J., & Lessnick, S. L. (2013) · Oncogene · doi:10.1038/onc.2012.525 · Cited by 167
“Ewing sarcoma provides an attractive model to understand the role of transcriptional regulation in tumor development because of its reliance on a single oncogenic transcription factor, EWS/FLI, created by the t(11;22)(q24;q12) chromosomal translocation (1).”
BackgroundUpdates on the cytogenetics and molecular genetics of bone and soft tissue tumors
Sandberg, A. A., & Bridge, J. A. (2001) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(01)00462-9 · Cited by 176
EWS–ETS oncoproteins: The linchpins of Ewing tumors
Janknecht, R. (2005) · Gene · doi:10.1016/j.gene.2005.08.007 · Cited by 173
Sankar, S., Theisen, E. R., Bearss, J., Mulvihill, T., Hoffman, L. M., Sorna, V., Beckerle, M. C., Sharma, S., & Lessnick, S. L. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0072 · Cited by 173
“Ewing sarcoma is a highly aggressive pediatric malignancy characterized by the presence of a translocationderived fusion oncoprotein and aberrant transcription factor, EWS/FLI (24).”
Sgouras, D. N., Athanasiou, M. A., Beal, G. J., Fisher, R. J., Blair, D. G., & Mavrothalassitis, G. J. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00160.x · Cited by 169
Fusion of the FUS and BBF2H7 genes in low grade fibromyxoid sarcoma
Storlazzi, C. T. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg237 · Cited by 168
“The FUS protein shows extensive sequence similarity with EWSR1 (previously called EWS), another protein appearing as the 50 partner in a number of sarcomas (10).”
BackgroundDomain Architectures and Characterization of an RNA-binding Protein, TLS
Iko, Y., Kodama, T. S., Kasai, N., Oyama, T., Morita, E. H., Muto, T., Okumura, M., Fujii, R., Takumi, T., Tate, S.-I., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408552200 · Cited by 168
Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: liposarcoma
Sandberg, A. A. (2004) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2004.08.005 · Cited by 166
Bridge, R. S., Rajaram, V., Dehner, L. P., Pfeifer, J. D., & Perry, A. (2006) · Modern Pathology · doi:10.1038/modpathol.3800486 · Cited by 168
“Reverse transcription polymerase chain reaction (RT-PCR) has been used most commonly to identify the precise fusion transcripts and the specific chromosomal breakpoints involved in the translocation”
MethodEWS/Fli-1 chimeric protein is a transcriptional activator.
Ohno, T., Rao, V. N., & Reddy, E. S. (1993) · PubMed · Cited by 167
Oncogenic TLS/ERG and EWS/Fli-1 fusion proteins inhibit RNA splicing mediated by YB-1 protein.
Chansky, H. A., Hu, M., Hickstein, D. D., & Yang, L. (2001) · PubMed · Cited by 196
Downing, J. R., Head, D. R., Parham, D. M., Douglass, E. C., Hulshof, M., Link, M., Motroni, T., Grier, H. E., Curcio-Brint, A., & Shapiro, D. N. (1993) · PubMed · Cited by 183
The diversity of soft tissue tumours with EWSR 1 gene rearrangements: a review
Fisher, C. (2014) · Histopathology · doi:10.1111/his.12269 · Cited by 163
“The most common rearrangement (in about 85% of cases) is t(11;22)(q24;q12), resulting in EWSR1–FLI1 fusion.(44) A further 10% of tumours have t(21;22)(q22;q12) with EWSR1–ERG fusion which can be detected immunophenotypically with the ERG antibody,(66) although reactivity of this with EWSR1–FLI tumours, possibly relate…”
BackgroundDiagnosis and treatment of Ewing sarcoma of the bone: a review article
Ozaki, T. (2015) · Journal of Orthopaedic Science · doi:10.1007/s00776-014-0687-z · Cited by 164
“The EWS-FLI1 fusion gene, which is caused by the t(11;22)(q24;q12) translocation, is the most common type of fusion gene: 85 % of ES tumors that exhibit the EWS gene rearrangement were found to possess this type of translocation [4, 5, 26].”
BackgroundInfluentialHuang, F., Greer, A., Hurlburt, W., Han, X., Hafezi, R., Wittenberg, G. M., Reeves, K., Chen, J., Robinson, D., Li, A., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-0835 · Cited by 164
“Furthermore, IGFBP-2, IGFBP-3, IGFBP-5, and IGFBP-7 were elevated 7-fold to 15-fold in the BMS-536924 acquired resistant cells compared with the parental sensitive cells (Fig.”
BackgroundInfluentialThe role of genetic testing in soft tissue sarcoma
Antonescu, C. R. (2006) · Histopathology · doi:10.1111/j.1365-2559.2005.02285.x · Cited by 160
Giovannini, M., Biegel, J. A., Serra, M., Wang, J. Y., Wei, Y. H., Nycum, L., Emanuel, B. S., & Evans, G. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117360 · Cited by 162
“3 (6) was the reverse primer on exon 9 of the human Fli 1 gene (Zucman,”
BackgroundMethodInfluentialBraun, B. S., Frieden, R., Lessnick, S. L., May, W. A., & Denny, C. T. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4623 · Cited by 162
“EWS/FLI is a fusion gene that is formed by an 11;22 chromosomal translocation characteristically found in Ewing’s sarcomas and primitive neuroectodermal tumors of childhood (7).”
BackgroundUndifferentiated Small Round Cell Sarcomas with Rare EWS Gene Fusions
Wang, L., Bhargava, R., Zheng, T., Wexler, L., Collins, M. H., Roulston, D., & Ladanyi, M. (2007) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2007.070053 · Cited by 161
“2, CD99, neurofilament EWS-ZNF278 t(1;22)(p36.”
Molecular characteristics and therapeutic vulnerabilities across paediatric solid tumours
Jones, D. T. W., Banito, A., Grünewald, T. G. P., Haber, M., Jäger, N., Kool, M., Milde, T., Molenaar, J. J., Nabbi, A., Pugh, T. J., et al. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0169-x · Cited by 161
Aynaud, M.-M., Mirabeau, O., Gruel, N., Grossetête, S., Boeva, V., Durand, S., Surdez, D., Saulnier, O., Zaïdi, S., Gribkova, S., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.049 · Cited by 171
“Ewing sarcoma (EwS) is a highly aggressive pediatric bone cancer that is defined by a pathognomonic recurrent somatic mutation: a fusion between the EWSR1 gene and an ETS family member, most frequently the FLI1 gene (Delattre et al., 1992; Gr€ unewald et al., 2018).”
BackgroundSelf-citationBeitel, G. J., Tuck, S., Greenwald, I., & Horvitz, H. R. (1995) · Genes & Development · doi:10.1101/gad.9.24.3149 · Cited by 160
Targeting CREB for Cancer Therapy: Friend or Foe
Xiao, X., Li, B. X., Mitton, B., Ikeda, A., & Sakamoto, K. M. (2010) · Current Cancer Drug Targets · doi:10.2174/156800910791208535 · Cited by 160
Oncogenic Partnerships: EWS-FLI1 Protein Interactions Initiate Key Pathways of Ewing's Sarcoma
Erkizan, H. V., Uversky, V. N., & Toretsky, J. A. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2261 · Cited by 169
Ewing Sarcoma with Novel Translocation t(2;16) Producing an In-Frame Fusion of FUS and FEV
Ng, T., O’Sullivan, M. J., Pallen, C. J., Hayes, M. M., Clarkson, P. W., Winstanley, M., Sorensen, P. H. B., Nielsen, T. O., & Horsman, D. E. (2007) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2007.070009 · Cited by 159
Fusion of the EWS-related gene TAF2N to TEC in extraskeletal myxoid chondrosarcoma.
Sjögren, H., Meis‐Kindblom, J. M., Kindblom, L. G., Åman, P., & Stenman, G. (1999) · PubMed · Cited by 159
Thaete, C., Brett, D., Monaghan, P., Whitehouse, S. K., Rennie, G. R., Rayner, E. L., Cooper, C. S., & Goodwin, G. H. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.585 · Cited by 170
Fligman, I., Lonardo, F., Jhanwar, S. C., Gerald, W. L., Woodruff, J. M., & Ladanyi, M. (1995) · Europe PMC (PubMed Central) · Cited by 157
Soft tissue tumors associated with EWSR1 translocation
Romeo, S. O., & Tos, A. P. D. (2009) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-009-0854-3 · Cited by 159
“The so-called Ewing's sarcoma translocation is the best known example of sarcoma translocation as it was the first one to be identified [35] as well as the first of which the involved genes were cloned [1, 2].”
BackgroundNord, K. H., Mertens, F., Jin, Y., Meis‐Kindblom, J. M., Kindblom, L., Behrendtz, M., Kalén, A., Mandahl, N., & Panagopoulos, I. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20201 · Cited by 155
“…44:97–102 (2005) fusion proteins in a number of sarcomas in combination with various transcription factor partners suggested to be tumor-specific (Delattre et al., 1992; Crozat et al., 1993; Rabbitts et al., 1993; Zucman et al., 1993a, 1993b; Ladanyi and Gerald, 1994; Panagopoulos et al., 1994;…”
BackgroundOwen, L. A., Kowalewski, A. A., & Lessnick, S. L. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001965 · Cited by 155
“terminal domain contributed by EWS [4].”
BackgroundCRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2
Chen, L., Alexe, G., Dharia, N. V., Ross, L., Iniguez, A. B., Conway, A. S., Wang, E. J., Veschi, V., Lam, N., Qi, J., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90793 · Cited by 152
“Rather, pediatric cancers typically possess a “master” oncogenic event, such as MLL fusion proteins in infant leukemias (2), EWS/FLI1 fusions in Ewing sarcoma (3), or MYCN amplification in neuroblastoma (4).”
Yang, L., Chansky, H. A., & Hickstein, D. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005739200 · Cited by 154
EWS/FLI1-induced manic fringe renders NIH 3T3 cells tumorigenic
May, W. A., Arvand, A., Thompson, A. D., Braun, B. S., Wright, M. M., & Denny, C. T. (1997) · Nature Genetics · doi:10.1038/ng1297-495 · Cited by 171
Shah, A. V., Birdsey, G. M., & RANDI, A. M. (2016) · Vascular Pharmacology · doi:10.1016/j.vph.2016.05.003 · Cited by 168
Levanon, D., Glusman, G., Bangsow, T., Ben‐Asher, E., Male, D. A., Avidan, N., Bangsow, C., Hattori, M., Taylor, T. D., Taudien, S., et al. (2001) · Gene · doi:10.1016/s0378-1119(00)00532-1 · Cited by 172
“FLI1 is located on chromosome 11 and participates in the t(11;22) translocation generating the EWS/FLI1 fusion transcript associated with Ewing's tumors (Delattre et al., 1992).”
BackgroundShimizu, K., Ichikawa, H., Tojo, A., Kaneko, Y., Maseki, N., Hayashi, Y., Ohira, M., Asano, S., & Ohki, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10280 · Cited by 144
Zhang, L., Eddy, A., Teng, Y.-T., Fritzler, M., Kluppel, M., Melet, F., & Bernstein, A. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.12.6961 · Cited by 147
“The human homolog of Fli-1 is rearranged in Ewing’s sarcoma and neuroepithelioma as a result of a reciprocal chromosomal t(11;22) translocation that fuses the DNA-binding ETS domain of Fli-1 to a novel Nterminal sequence of a gene called EWS derived from chromosome 22 (8).”
BackgroundProtein disorder in the human diseasome: unfoldomics of human genetic diseases
Midic, U., Oldfield, C. J., Dunker, A. K., Obradovic, Z., & Uversky, V. N. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-s1-s12 · Cited by 145
“These tumors share a recurrent and specific t(11;22) (q24;q12) chromosome translocation [112], which combines the N-terminus of EWS (residues 1–264) from chromosome 22 with the Cterminus of FLI1 (232 carboxy-terminal residues) from chromosome 11 to form EWS-FLI1 fusion protein, a chimeric transcription factor.”
BackgroundA Solid-State Conceptualization of Information Transfer from Gene to Message to Protein
Kato, M., & McKnight, S. L. (2018) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-044700 · Cited by 143
EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro.
Kovar, H., Aryee, D. N. T., Jug, G., Henöckl, C., SCHEMPER, M., Delattre, O., Thomas, G. D., & Gadner, H. (1996) · PubMed · Cited by 190
Self-citationHuman Genome and Diseases:¶Double-strand breaks and translocations in cancer
Elliott, B., & Jasin, M. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8429-3 · Cited by 177
Tirado, O. M., Mateo-Lozano, S., Villar, J., Dettin, L. E., Llort, A., Gallego, S., Ban, J., Kovar, H., & Notario, V. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0927 · Cited by 143
“These EWS/FLI-1 genes are heterogeneous with regard to the location of the translocation junction, resulting in different breakpoints (3).”
Self-citationEwing sarcoma gene EWS is essential for meiosis and B lymphocyte development
Li, K., Watford, W. T., Li, C., Parmelee, A., Bryant, M., Deng, C., O’Shea, J. J., & Lee, S. B. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31222 · Cited by 157
“The carboxyterminal domain (CTD) of EWS contains an RNA recognition motif (RRM), 3 RGG box domains, and a Ran-binding protein 2–like (RanBP2-like) zinc finger motif (1).”
BackgroundUpdates on cytogenetics and molecular genetics of bone and soft tissue tumors:
Sandberg, A. A., & Bridge, J. A. (2000) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(00)00295-8 · Cited by 165
Stegmaier, K., Wong, J. S., Ross, K. N., Chow, K. T., Peck, D., Wright, R. D., Lessnick, S. L., Kung, A. L., & Golub, T. R. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040122 · Cited by 143
“Over ten years ago, the translocation t(11;22)(q24;q12) was characterized and subsequently identified in over 80% of patients with Ewing sarcoma, yet no oncoprotein-directed therapy has been developed [2,4].”
Gene fusions in soft tissue tumors: Recurrent and overlapping pathogenetic themes
Mertens, F., Antonescu, C. R., & Mitelman, F. (2015) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22335 · Cited by 155
“Bone Delattre et al., 1992 EWSR1-NR4A3 ESMCS (70”
BackgroundWaldman, W. J., Knight, D. A., Blinder, L., Shen, J., Lurain, N. S., Miller, D. M., Sedmak, D. D., Williams, J. W., & Chong, A. S. (1999) · Intervirology · doi:10.1159/000053979 · Cited by 145
Harnessing the Immunotherapy Revolution for the Treatment of Childhood Cancers
Majzner, R. G., Heitzeneder, S., & Mackall, C. L. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.03.002 · Cited by 151
Adamantinoma-like Ewing's Sarcoma: Genomic Confirmation, Phenotypic Drift
Bridge, J. A., Fidler, M. E., Neff, J. R., Degenhardt, J., Wang, M., Walker, C. W., Dorfman, H. D., Baker, K. S., & Seemayer, T. A. (1999) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199902000-00004 · Cited by 144
Retroviral insertional mutagenesis:Tagging cancer pathways
Mikkers, H. M. M., & Berns, A. J. M. (2003) · Advances in cancer research · doi:10.1016/s0065-230x(03)88304-5 · Cited by 161
Tat-SF1: Cofactor for Stimulation of Transcriptional Elongation by HIV-1 Tat
Zhou, Q., & Sharp, P. A. (1996) · Science · doi:10.1126/science.274.5287.605 · Cited by 143
Chen, S. D., Denız, K., Sung, Y., Zhang, L., Dry, S., & Antonescu, C. R. (2015) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22336 · Cited by 141
“The genetic hallmark of Ewing sarcoma (ES) is the recurrent t(11;22)(q24;q12) translocation resulting in the fusion of EWSR1 and FLI1 genes, identified in 90% of cases (Delattre et al., 1992, 1994).”
BackgroundContribution of molecular genetic data to the classification of sarcomas
Ladanyi, M., & Bridge, J. A. (2000) · Human Pathology · doi:10.1053/hp.2000.6706 · Cited by 141
Molecular phylogeny of the ETS gene family
Laudet, V., Hänni, C., Stéhelin, D., & Duterque-Coquillaud, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202444 · Cited by 139
“…induce the fusion of carboxy-terminal domains of Fli-1, Erg, Etv-1 and Pea3, and recently Fev, with the amino-terminal half of Ews, an RNA binding protein encoded by the ews gene (Delattre et al., 1992; Sorensen et al., 1994; Jeon et al., 1996; Urano et al., 1996; Peter et al., 1997).”
BackgroundDjavaheri-Mergny, M., Javelaud, D., Wietzerbin, J., & Besançon, F. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.10.082 · Cited by 134
Dr. Jekyll and Mr. Hyde: The Two Faces of the FUS/EWS/TAF15 Protein Family
Kovar, H. (2010) · Sarcoma · doi:10.1155/2011/837474 · Cited by 154
“The prototype FET protein EWS was identified in 1992 as the gene product encoded by the Ewing’s sarcoma breakpoint region 1 (EWSR1) on chromosome 22q12 constituting the first identified member of a family of putative RNA-binding proteins [3], including also FUS/TLS/Pigpen/hnRNP P2 [4– 7], TAF15/hTAFII68/TAF2N/RPB56 [8…”
BackgroundSelf-citationErratum: Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma
Sankar, S., Bell, R. N., Stephens, B. J., Zhuo, R., Sharma, S., Bearss, D. J., & Lessnick, S. L. (2016) · Oncogene · doi:10.1038/onc.2016.142 · Cited by 139
The ets transcription factor Fli-1 in development, cancer and disease
Li, Y., Luo, H., Liu, T., Zacksenhaus, E., & Ben-David, Y. (2015) · Oncogene · doi:10.1038/onc.2014.162 · Cited by 133
The EWS–WT1 gene fusion in desmoplastic small round cell tumor
Gerald, W. L., & Haber, D. A. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.01.005 · Cited by 145
Metadata
- Authors
- Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., Aurias, A., & Thomas, G.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Venue
- Nature
- Published
- 1992-09
- Volume
- 359
- Issue
- 6391
- Pages
- 162-165
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2069351898
- Cited by
- 1,907
- References
- 30
- Citations by year
- 2026: 57 · 2025: 72 · 2024: 69 · 2023: 64 · 2022: 78 · 2021: 83 · 2020: 80 · 2019: 69 · 2018: 54 · 2017: 57 · 2016: 71 · 2015: 62 · 2014: 61 · 2013: 63 · 2012: 45
- FWCI
- 60.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- Ewing sarcoma, primitive neuroectodermal tumor, 22)(q24, EWSR1, gene fusion, chromosomal translocation, RNA-binding domain
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Chromosomes, Human, Pair 11, Chromosomes, Human, Pair 22, Cloning, Molecular, Gene Frequency, Humans, Molecular Sequence Data, Nucleic Acid Hybridization, Sarcoma, Ewing, Sequence Homology, Nucleic Acid, Transcription, Genetic, Translocation, Genetic, Restriction Mapping, DNA Probes, Polymerase Chain Reaction, Open Reading Frames, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.